Mitral Holdco

Mitral is a medical technology company headquartered in the United Kingdom that specializes in the development of transcatheter solutions for structural heart disease. The company's lead product, the Mitra-Fix system, is an innovative percutaneous edge-to-edge repair (TEER) device designed to treat patients suffering from mitral regurgitation. Founded by renowned cardiac surgeon Professor Stephen Westaby, Mitral aims to provide a safer, less invasive alternative to traditional open-heart surgery, particularly for high-risk patient populations. The Mitra-Fix technology utilizes a unique delivery and anchoring mechanism to reduce mitral valve leakage and improve cardiac function. The company is currently advancing its platform through clinical trials to establish safety and efficacy for regulatory approval.